Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.
Volatility and Risk
Valion Bio, Inc. Common Stock has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.
Institutional and Insider Ownership
4.3% of Valion Bio, Inc. Common Stock shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 14.5% of Valion Bio, Inc. Common Stock shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Valion Bio, Inc. Common Stock | N/A | -138.10% | -63.67% |
| KORU Medical Systems | -5.27% | -13.61% | -8.33% |
Valuation and Earnings
This table compares Valion Bio, Inc. Common Stock and KORU Medical Systems”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Valion Bio, Inc. Common Stock | N/A | N/A | -$8.88 million | ($6.68) | -0.13 |
| KORU Medical Systems | $41.13 million | 4.63 | -$2.64 million | ($0.05) | -83.00 |
KORU Medical Systems has higher revenue and earnings than Valion Bio, Inc. Common Stock. KORU Medical Systems is trading at a lower price-to-earnings ratio than Valion Bio, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations for Valion Bio, Inc. Common Stock and KORU Medical Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Valion Bio, Inc. Common Stock | 1 | 0 | 0 | 0 | 1.00 |
| KORU Medical Systems | 1 | 0 | 4 | 0 | 2.60 |
KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 74.70%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Valion Bio, Inc. Common Stock.
Summary
KORU Medical Systems beats Valion Bio, Inc. Common Stock on 10 of the 13 factors compared between the two stocks.
About Valion Bio, Inc. Common Stock
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Valion Bio Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valion Bio Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
